Analyst Ratings for [VTR] Ventas, Inc.

10/1/25	Initiated	Overweight	X
VTR Ventas Cantor Fitzgerald
$77
9/19/25	Initiated	Neutral	X
VTR Ventas UBS
$73
6/23/25	Upgrades	Neutral Overweight	X
VTR Ventas JP Morgan
$72
3/7/25	Upgrades	Hold Buy	X
VTR Ventas Argus
1/17/25	Upgrades	Neutral Outperform	X
VTR Ventas Robert W. Baird
$66 $65
10/1/24	Upgrades	Eq Weight Overweight	X
VTR Ventas Wells Fargo
$61 $71
3/18/24	Upgrades	In-line Outperform	X
VTR Ventas Evercore ISI
$50
2/26/24	Downgrades	Overweight Eq Weight	X
VTR Ventas Wells Fargo
$52 $46
1/30/24	Initiated	Buy	X
VTR Ventas Deutsche Bank
$60
1/16/24	Upgrades	Neutral Buy	X
VTR Ventas BofA Securities
$48 $53
11/7/23	Upgrades	Neutral Outperform	X
VTR Ventas Wedbush
$44 $51
10/11/23	Initiated	Outperform	X
VTR Ventas Exane BNP Paribas
$47
10/3/23	Initiated	Neutral	X
VTR Ventas Wedbush
$44
9/20/23	Downgrades	Strong Buy Outperform	X
VTR Ventas Raymond James
$55 $53
8/11/23	Downgrades	Buy Neutral	X
VTR Ventas BofA Securities
$54 $48
6/23/23	Upgrades	Outperform Strong Buy	X
VTR Ventas Raymond James
$55
4/20/23	Initiated	Overweight	X
VTR Ventas Wells Fargo
$50
11/1/22	Reiterated	Outperform	X
VTR Ventas Credit Suisse
$63 $48
11/1/22	Downgrades	Strong Buy Outperform	X
VTR Ventas Raymond James
$55 $46
10/10/22	Downgrades	Outperform Neutral	X
VTR Ventas Robert W. Baird
$38
6/30/22	Upgrades	Hold Buy	X
VTR Ventas Jefferies
$58 $59
6/23/22	Initiated	Outperform	X
VTR Ventas Credit Suisse
$63
6/3/22	Initiated	Overweight	X
VTR Ventas CapitalOne
$63
5/18/22	Upgrades	Neutral Outperform	X
VTR Ventas Credit Suisse
$53 $63
3/11/22	Upgrades	Mkt Perform Outperform	X
VTR Ventas BMO Capital Markets
$57 $67
3/11/22	Upgrades	Neutral Buy	X
VTR Ventas BofA Securities
$65
2/1/22	Initiated	Neutral	X
VTR Ventas Credit Suisse
$53
1/20/22	Upgrades	Neutral Buy	X
VTR Ventas Mizuho
$45 $61
11/22/21	Downgrades	Outperform Neutral	X
VTR Ventas SMBC Nikko
$55
10/4/21	Resumed	Equal-Weight	X
VTR Ventas Morgan Stanley
$60
7/14/21	Resumed	Neutral	X
VTR Ventas Mizuho
$45
6/15/21	Initiated	Outperform	X
VTR Ventas Wolfe Research
$71
6/11/21	Upgrades	Eq Weight Overweight	X
VTR Ventas Barclays
$53 $67
5/13/21	Upgrades	Underweight Overweight	X
VTR Ventas KeyBanc Capital Markets
$60
5/13/21	Upgrades	Neutral Outperform	X
VTR Ventas Robert W. Baird
$58
1/8/21	Downgrades	Mkt Perform Underperform	X
VTR Ventas BMO Capital Markets
$49
1/6/21	Initiated	Neutral	X
VTR Ventas Robert W. Baird
$49
6/21/19	Reiterated	Neutral	X
VTR Ventas BofA/Merrill
$67 $72.50
6/20/19	Upgrades	Neutral Buy	X
VTR Ventas Citigroup
6/20/19	Upgrades	Underperform In-line	X
VTR Ventas Evercore ISI
$63 $68
6/20/19	Upgrades	Hold Buy	X
VTR Ventas Stifel
$65 $74
4/30/19	Upgrades	Underperform Mkt Perform	X
VTR Ventas Raymond James
3/28/19	Initiated	Equal-Weight	X
VTR Ventas Morgan Stanley
$61
11/2/18	Downgrades	Outperform Sec Perform	X
VTR Ventas RBC Capital Mkts
10/30/18	Initiated	Neutral	X
VTR Ventas JP Morgan
$60
5/21/18	Downgrades	In-line Underperform	X
VTR Ventas Evercore ISI
4/27/18	Upgrades	Neutral Long-term Buy	X
VTR Ventas Hilliard Lyons
1/30/18	Upgrades	Underperform In-line	X
VTR Ventas Evercore ISI

VTR Ventas, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.